LIPOCINE INC. Cash Equivalents, at Carrying Value
LIPOCINE INC. (LPCN) had Cash Equivalents, at Carrying Value of $5.20 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-03-10
- 2025-12-31: Cash Equivalents, at Carrying Value $5.20M.
- 2024-12-31: Cash Equivalents, at Carrying Value $6.20M.
- 2023-12-31: Cash Equivalents, at Carrying Value $4.80M.
- 2022-12-31: Cash Equivalents, at Carrying Value $3.10M.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2025-12-31 | $5.20M 10-K · filed 2026-03-10 | |
| 2024-12-31 | $6.20M 10-K · filed 2026-03-10 | |
| 2023-12-31 | $4.80M 10-K · filed 2025-03-13 | |
| 2022-12-31 | $3.10M 10-K · filed 2024-03-07 | |
| 2021-12-31 | $3.00M 10-K · filed 2023-03-10 | |
| 2020-12-31 | $19.20M 10-K · filed 2022-03-09 | |
| 2019-12-31 | $9.70M 10-K · filed 2021-03-11 | |
| 2018-12-31 | $8.10M 10-K · filed 2020-03-13 | $7.30M 10-K · filed 2019-03-06 |
| 2017-12-31 | $2.20M 10-K · filed 2019-03-06 | |
| 2016-12-31 | $2.90M 10-K · filed 2018-03-12 | $2.92M 10-K · filed 2017-03-06 |
| 2015-12-31 | $128.00K 10-K · filed 2017-03-06 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-10 | |
| 2013-12-31 | $1.90M 10-K · filed 2014-03-31 | |
| 2012-12-31 | $2.70M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |